
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
Cellzome is a privately-owned drug discovery company identifying a new generation of kinase- targeted drugs to treat inflammatory diseases. Its pipeline of small-molecule therapeutics is driven by KinobeadsTM, a proprietary technology for the screening and profiling of kinases in relevant cells and tissues. Cellzome is applying its distinctive KinobeadsTM technology to the discovery and development of novel, selective, kinase inhibitors targeting key inflammatory mediators in immune receptor signalling and chemotaxis, including PI3K and Zap-70
Proteomics,drug discovery,and inflammation
Cellzome operates in the Pharmaceutical manufacturing industry.
Cellzome's revenue is 11m - 100m
Cellzome has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.